how are companies still selling compounded semaglutide Hims & Hers stock falls 25% as FDA curtails GLP-1s 🚨 FDA Moves to Shut

[Abstract] Autophagy

Unlike the narrow windows created by some ED medications, this treatment provides extended readiness without pressure to perform within a specific timeframe

It depends on your plan and diagnosis: Most Illinois insurance plans cover GLP-1s for diabetes (Ozempic, Mounjaro.) Coverage for obesity (Wegovy, Zepbound) varies significantly Blue Cross Blue Shield of Illinois: Variable by plan, often requires BMI 30+ and prior weight loss attempts UnitedHealthcare: Many plans exclude obesity medications entirely Aetna: Some plans cover with prior authorization Illinois Medicaid: Covers for diabetes, limited obesity coverage We help with prior authorizations and appeals

The paradigm shifted dramatically with the release of multi-society guidance in October 2024, endorsed by the ASA, American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and Society of American Gastrointestinal and Endoscopic Surgeons [10]

PMID: 54 HarveyCJThimmulappaRKSinghABlakeDJLingGWakabayashiNet al

This focuses on the need for supportive strategies that can maximize benefit and minimize barriers